Literature DB >> 20726711

Fractionated radiation therapy can induce a molecular profile for therapeutic targeting.

Molykutty John-Aryankalayil1, Sanjeewani T Palayoor, David Cerna, Charles B Simone, Michael T Falduto, Scott R Magnuson, C Norman Coleman.   

Abstract

To examine the possibility of using fractionated radiation in a unique way with molecular targeted therapy, gene expression profiles of prostate carcinoma cells treated with 10 Gy radiation administered either as a single dose or as fractions of 2 Gy × 5 and 1 Gy × 10 were examined by microarray analysis. Compared to the single dose, the fractionated irradiation resulted in significant increases in differentially expressed genes in both cell lines, with more robust changes in PC3 cells than in DU145 cells. The differentially expressed genes (>twofold change; P < 0.05) were clustered and their ontological annotations evaluated. In PC3 cells genes regulating immune and stress response, cell cycle and apoptosis were significantly up-regulated by multifractionated radiation compared to single-dose radiation. Ingenuity Pathway Analysis (IPA) of the differentially expressed genes revealed that immune response and cardiovascular genes were in the top functional category in PC3 cells and cell-to-cell signaling in DU145 cells. RT-PCR analysis showed that a flexure point for gene expression occurred at the 6th-8th fraction and AKT inhibitor perifosine produced enhanced cell killing after 1 Gy × 8 fractionated radiation in PC3 and DU145 cells compared to single dose. This study suggests that fractionated radiation may be a uniquely exploitable, non-oncogene-addiction stress pathway for molecular therapeutic targeting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726711     DOI: 10.1667/RR2105.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  27 in total

1.  Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors:  Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.

Authors:  Charles B Simone; Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

3.  Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Adeola Makinde; Iris Eke; Joel Levin; Uma Shankavaram; Laurel MacMillan; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Biomarkers       Date:  2018-06-19       Impact factor: 2.658

4.  The Radiation Stress Response: Of the People, By the People and For the People.

Authors:  C Norman Coleman
Journal:  Radiat Res       Date:  2017-01-24       Impact factor: 2.841

5.  Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Joel Levin; Iris Eke; Adeola Makinde; Shaoli Das; Uma Shankavaram; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Radiat Res       Date:  2018-01-08       Impact factor: 2.841

6.  Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.

Authors:  Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Charles B Simone; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Radiat Res       Date:  2012-07-24       Impact factor: 2.841

7.  Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.

Authors:  Sanjeewani T Palayoor; Molykutty John-Aryankalayil; Adeola Y Makinde; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Mol Cancer Res       Date:  2014-04-30       Impact factor: 5.852

Review 8.  Radiotherapy: Changing the Game in Immunotherapy.

Authors:  Sandra Demaria; C Norman Coleman; Silvia C Formenti
Journal:  Trends Cancer       Date:  2016-06

9.  RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Authors:  Ryan C Widau; Akash D Parekh; Mark C Ranck; Daniel W Golden; Kiran A Kumar; Ravi F Sood; Sean P Pitroda; Zhengkai Liao; Xiaona Huang; Thomas E Darga; David Xu; Lei Huang; Jorge Andrade; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 10.  Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.

Authors:  Adeola Y Makinde; Iris Eke; Molykutty J Aryankalayil; Mansoor M Ahmed; C Norman Coleman
Journal:  Semin Radiat Oncol       Date:  2016-07-05       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.